Project Grant R01CA291768
Award Date
8/1/24
Completion Date
7/31/29
Dollars Obligated
$578K
Federal Agency
National Cancer Institute
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
93.395
Assistance Type
Project Grant
Place of Performance
Durham, NC 27710, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $1,123,468 Project Grant (CFDA 93.395 - Cancer Treatment Research) to Duke University to conduct a randomized controlled trial (RCT) of a hybrid-delivered cognitive behavioral symptom management and activity coaching intervention for hematopoietic stem cell transplant (HCT) patients. The goal is to use mobile health (mHealth) technology approaches to enable HCT patients to effectively cope with symptoms like fatigue, pain, and distress that interfere...
The National Cancer Institute (NCI) awarded a $621,732 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to The Medical University of South Carolina (MUSC) to evaluate a proactive identification and digital mental health intervention approach to address unmet psychosocial needs of individuals living with likely incurable cancer. The project aims to: 1) comprehensively assess the effectiveness of a proactive identification and digital mental health intervention...
The National Cancer Institute (NCI), part of the National Institutes of Health, awarded a $664,259 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Duke University. The award, effective August 6, 2024 through July 31, 2029, supports the development and evaluation of an accessible digital health intervention called "AYA STEPS" (Symptom Management and Transitioning to Engagement with Post-Treatment Care for Adolescent and Young Adult Cancer...
The National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research (CFDA 93.393) program, awarded a $656,014 Project Grant to The Ohio State University to conduct a randomized clinical trial of a telemedicine-mHealth symptom cluster intervention for advanced cancer patients in underserved rural communities. The 5-year study, titled "Randomized Clinical Trial of a Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Increasing Access in...
The National Cancer Institute (NCI) awarded a $526,602 Project Grant (CFDA 93.398 - Cancer Research Manpower) to Duke University to conduct a pilot randomized controlled trial of a mindfulness-based intervention called NITE2DAY+ for improving sleep disturbance and other symptoms in hematologic cancer patients during and after inpatient treatment. The intervention will be delivered via a self-paced mobile app and include mindfulness meditations, sleep education, and behavioral strategies to...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $858,166 to The General Hospital Corporation, doing business as Massachusetts General Hospital, to conduct a randomized trial of a targeted palliative care intervention for patients with metastatic breast cancer. The study aims to improve documentation of patients' end-of-life care preferences, delivery of end-of-life care, and participant-reported outcomes. The...
This $599,339 federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will fund a randomized trial to test the efficacy of the HORIZONS multi-disciplinary telehealth intervention for improving quality of life, psychological distress, symptom burden, coping, and self-efficacy in 350 patients with chronic graft-versus-host disease (cGVHD) following hematopoietic stem cell transplant. The 5-year study will be conducted by the University of...
The National Cancer Institute (NCI) awarded Emory University a 5-year, $708,091 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to test the effectiveness of the Algorithm-Enabled Patients Activated in Cancer Care through Teams (A-PACT) intervention. A-PACT uses machine learning to automatically identify high-risk cancer patients and connect them with lay health workers to facilitate structured education and goal-of-care conversations. The project aims to reduce...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $979,000 to the Beckman Research Institute of the City of Hope to develop and evaluate a blended e-health intervention for addressing fear of progression (FOP) in patients with advanced gynecologic cancer. The intervention consists of group videoconferencing sessions, web-based self-study modules, and facilitator check-in calls, focusing on topics such as the cancer experience, values/goal...
The National Cancer Institute (NCI) awarded a $638,326 Project Grant (CFDA 93.395 - Cancer Treatment Research) to the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. The grant supports the adaptation and preliminary evaluation of an intervention called "ENERGIZE-MBC" - a cognitive behavioral therapy for fatigue among women with metastatic breast cancer treated with CDK4/6 inhibitors. The key products and services to be delivered under this grant include: Adapting...